Ligand validation:5THU

B3N: 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide

B3N is a Ligand Of Interest in 5THU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5THU_B3N_A_404	52%	28%	0.168	0.925	1.81	1.11	4	2	2	0	100%	0.95
5THU_B3N_B_404	40%	18%	0.205	0.918	1.9	1.62	2	2	1	0	100%	0.93
5THV_B3N_B_404	86%	30%	0.103	0.973	1.59	1.22	3	3	0	0	100%	1
7JVW_B3N_A_501	66%	71%	0.157	0.962	0.34	0.77	-	-	2	0	100%	1
4QA1_B3N_B_404	65%	64%	0.141	0.944	0.38	0.98	-	-	1	0	100%	1
4QA4_B3N_A_501	63%	67%	0.162	0.959	0.31	0.93	-	1	0	0	100%	1
5DC5_B3N_B_403	59%	58%	0.181	0.965	0.36	1.24	-	4	1	0	100%	1
4RSY_B3N_A_701	76%	51%	0.11	0.947	0.88	1	1	2	0	0	100%	1
3Q9B_B3N_A_401	67%	29%	0.138	0.947	2.11	0.79	8	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.